find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
298
Clinical Trials
Genito-Urinary
Phase II
Active
nct/study# NCT04164082 / A031803
Phase II Trial Of Intravesical Gemcitabine And MK-3475 (Pembrolizumab) In The Treatment Of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Learn More
Genito-Urinary
Phase III
Active
nct/study# NA / AV-951-20-304
A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study To Compare Tivozanib In Combination With Nivolumab To Tivozanib In Subjects With Renal Cell Carcinoma Who Have Progressed Following One Or Two Lines Of Therapy, One Of Which Is An Immune Checkpoint Inhibitor
Learn More
Genito-Urinary
Phase II/III
Active
nct/study# NCT04628767 / EA8192
A Phase II/III Trial Of MEDI4736 (Durvalumab) And Chemotherapy For Patients With High Grade Upper Tract Urothelial Cancer Prior To Nephroureterectomy
Learn More
Leukemia
NA
Accepting Patients
nct/study# NCT01688011 / AZA-MDS-006
Connect MDS And AML: The Myelodysplastic Syndromes (MDS) And Acute Myeloid Leukemia (AML) Disease Registry
Learn More
Leukemia
NA
Accepting Patients
Leukemia
Phase I
Accepting Patients
nct/study# NCT03555955 / CPX351-102
A Phase 1 Trial To Evaluate The Potential Impact Of Renal Impairment On The Pharmacokinetics And Safety Of CPX-351 (Daunorubicin And Cytarabine) Liposome For Injection Treatment In Adult Patients With Hematologic Malignancies
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.